Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
cancer
national
new york blog main
new york top stories
novartis
boston blog main
boston top stories
bristol-myers squibb
cancer drugs
cancer immunotherapy
deals
fda
national top stories
new york
samit hirawat
san francisco blog main
san francisco top stories
takeda pharmaceutical
abbvie
agios pharmaceuticals
alex gorsky
allergan aesthetics
alzheimer's disease
amgen
ashley mcevoy
astrazeneca
athira pharma
attralus
auris health
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
What
company’s
5
×
pipeline
medical
acquisition
anniversary
approaches
bn
bristol
buy
celgene
chief
clinical
corporation
diversity
hirawat
myers
myers’s
officer
progress
scrip
spoke
squibb
trial
year
acquiring
acquisitions
auris
biggest
billion
bio
build
builds
cash
ceo
course
daniel
deal
debut
developer
development
Language
unset
Current search:
company’s
×
biotech
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
